期刊文献+

凝血酶增高NMDA受体敏感性与组织型谷氨酰胺转移酶的关系 被引量:2

Enhancement of NMDA receptor sensitivity by thrombin and its relationship with tissue transglutaminase
原文传递
导出
摘要 目的探讨凝血酶增高大鼠的小脑颗粒细胞N-甲基-D-天冬氨酸受体(NMDA)敏感性是否与细胞内组织型谷氨酰胺转移酶(tTG)变化有关.方法以0.01 U/ml浓度凝血酶单独或与tTG抑制剂单丹磺酰尸胺(MDC) 0.5×10-4 mol/L处理原代培养的Wistar大鼠小脑颗粒细胞30 min后,以0.1×10-4 mol/L、0.25×10-4 mol/L和0.5×10-4 mol/L 3种浓度NMDA作用3 h诱导上述处理的细胞凋亡,比较流式细胞仪检测到的细胞凋亡率差异以判断NMDA受体敏感性的变化;RT-PCR和Gelpro图像分析软件检测各NMDA浓度有/无凝血酶预处理的细胞内tTG mRNA变化差异.结果凝血酶预处理细胞后上述3种浓度NMDA诱导的细胞凋亡率均升高[(8.3±0.5~15.1±0.8)%, (14.1±1.1~23.8±0.7)%, (26.8±1.9~33.7±2.1)%].预处理细胞时加入MDC可阻断凝血酶对NMDA受体的这种影响,细胞凋亡率降至(5.8±1.2)%、(11.5±1.5)%和(19.0±1.7)%;凝血酶预处理后各浓度NMDA处理细胞内tTG mRNA量均同一浓度单独NMDA处理的细胞高.结论凝血酶通过增高细胞内tTG使小脑颗粒细胞NMDA受体敏感性增高. Objective To explore the possible relationship between the thrombin induced potentiation of rat cerebellum granular cell N-methyl-D-aspartate (NMDA) receptor function and the change of intracellular tissue transglutaminase (tTG). Methods Primary cultured rat cerebellum granular cells were pretreated by using thrombin (0. 01 U/ml) with or without co-pretreatement of 0. 5 × 10^-4 mol/L MDC (monodansylcadaverine, a tTG inhibitor) 30 minutes. Induce cells mentioned above to undergo apoptosis with different concentration of NMDA (0. 1 × 10^-4 tool/L,0. 25 × 10^-4mol/L and 0. 5 × 10^-4 mol/L) . Flowcytometer was applied 3 hours later to detect the changed function of NMDA receptor by counting percentage of apoptotic cells. RT-PCR was used to compare the tTG mRNA level in the cerebellum granular cells treated with NMDA of same dosage with/without thrombin pretreatment. Results Thrombin pretreatment increased the percentage of apoptosis cells induced by NMDA [ ( 8. 3 ± 0.5 ) % to ( 15. 1 ± 0.8)% at0. 1 xl0-4 mol/L,(14. 1 ±1.1)% to (23.8±0.7)% at 0.25×10^-4 mol/L, (26.821.9)% to (33.7 22. 1)% at 0.5 × 10^-4 mol/L) ] ; and this effect was inhibited by co-pretreatment MDC with thrombin, cell apoptosis decreased to ( 5. 8±1.2 ) %, ( 11.5±1.5 ) % and ( 19. 0±1.7 ) % ; Thrombin increased intracellular tTG mRNA levels comparing with those without thrombin pretreatment. Conclusion Thrombin potentiates rat cerebellum granular cell NMDA receptor function by increasing intracellular tissue transglutaminase.
出处 《中华内科杂志》 CAS CSCD 北大核心 2005年第9期668-671,共4页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献10

  • 1Gong C, Boulis N, Qian J, et al. Intracerebral hemorrhage-induced neuronal death. Neurosurgery, 2001,48:875-882.
  • 2Donovan FM, Pike CJ, Cotman CW, et al. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci, 1997,17:5316-5326.
  • 3Gingrich MB, Junge CE, Lyuboslavsky P, et al. Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci, 2000,20:4582-4595.
  • 4曾非,余绍祖,陈谦学.凝血酶诱导皮质神经元凋亡及其机制研究[J].中华实验外科杂志,2004,21(12):1508-1510. 被引量:5
  • 5Laurie DJ, Seeburg PH. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA.J Neurosci,1994,14(5 Pt 2):3180-3194.
  • 6Striggow F, Riek M, Breder J, et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.Proc Natl Acad Sci U S A,2000,97:2264-2269.
  • 7Burnashev N, Schoepfer R, Monyer H, et al. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science,1992,257:1415-1419.
  • 8马春林,谭晓帆.65例自发性脑出血后早期癫痫发作的临床分析[J].卒中与神经疾病,2001,8(4):238-239. 被引量:12
  • 9Jing G, Grammatopoulos T, Ferguson P, et al. Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures. Brain Res Bull, 2004,62:397-403.
  • 10Ientile R, Caccamo D, Macaione V, et al. NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells. Neuroscience,2002,115:723-729.

二级参考文献9

  • 1刘柱仁,黄经纬.脑出血后癫痫30例分析[J].中风与神经疾病杂志,1993,10(3):167-168. 被引量:14
  • 2程保合 韩仲岩.脑血管病与癫痫.实用脑血管病学[M].上海:上海科学技术文献出版社,1994.325-327.
  • 3Slaughter TF,Achyuthan KE,Lai TS,et al.A microtitre plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate.Ann Biochem,1992,205:166-171.
  • 4Mendelow AD.Mechanisms of ischemic brain damage with intracerebral hemorrhage.Stroke,1993,24:115-119.
  • 5Hand D,Perry MJ,Haynes LW.Cellular transglutaminases in neural development.Int J Dev Neurosci,1993,11:709-720.
  • 6Milakovic T,Tucholski J,McCoy E,et al.Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death.J Biol Chem,2004,279:8715-8722.
  • 7Greenberg CS,Birckbichler PJ,Rice RH.Transglutaminases:multifunctional cross-linking enzymes that stabilize tissues.FASEB J,1991,5:3071-3077.
  • 8陈秀芸,黄向东.脑卒中后癫痫的临床研究[J].中国实用内科杂志,1997,17(11):661-662. 被引量:32
  • 9瞿文军,徐如祥.乙酰半胱氨酸水平与单胺类物质所致神经元损害的关系[J].中华实验外科杂志,2003,20(2):153-154. 被引量:2

共引文献15

同被引文献13

  • 1曾非,余绍祖,陈谦学.凝血酶诱导皮质神经元凋亡及其机制研究[J].中华实验外科杂志,2004,21(12):1508-1510. 被引量:5
  • 2包新民 舒斯云 著.人鼠脑立体定位图谱[M].北京:人民卫生出版社,1991.19,22,55.
  • 3Lee KR,Colon GP,Betz AL,et al.Edema from intracerbral hemorrhage:the role of thrombin.J Neurosurg,1996,84(1):91-96.
  • 4Markwardt F.Past,present,and future of hirudin.Haemostasis,1991,21(suppl):11-26.
  • 5Presta M,Ennas MG,Torelli S,et al.Synthesis of urokinasetype plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain:stimulation by phorbol ester.J Neurochem,1990,55(5):1647-1654.
  • 6Kumazawa T,Seno H,Urakami T,et al.Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry.Biochim Biophys Acta,1992,56(1):62
  • 7Liu S,Li H,Ou Yang J,et al.Fnhanced rat sciatic nerve regeneration through silicon tubes filled with pyrroloquinoline quinone,Microsurgery,2005,25(4):329
  • 8Ora N,Nakajima T,Nakazawa I,et al,A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.Hum Genet,2001,46 (5):267
  • 9Terry CF,Loukaci V,Green FR.Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation.Jour of Bio Chem,2000,275(24):18138
  • 10Kitamura A,Hasegawa G,Obayashi H,et al.Interleukin-6 poly morphism(-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes.Diabet Med,2002,19(12):1000

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部